[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Recreational Oxygen Equipment Market Size, Share & Trends Analysis Report By Product (Oxygen Concentrators, Oxygen Bar Equipment), By Application (Athletics, Medical), By Region, And Segment Forecasts, 2024 - 2030

September 2024 | 100 pages | ID: RD72ECC4AFB0EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Recombinant DNA Technology Market Growth & Trends

The global recombinant DNA technology market size is expected to reach USD 1,067.1 billion by 2030, expanding at a CAGR of 5.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The success of genetically engineered human insulin in diabetes treatment has triggered the development of many other recombinant therapeutics and drugs. This has translated to the huge success of Recombinant DNA (rDNA) technology. This technology has offered significant prospects for elucidating the gap between disease and its effective treatment.

Widespread successful application of this technique in veterinary product development, genetically modified crop development, biopesticides & biofuel production, and gene therapy, are expected to spur the adoption of this technology throughout the forecast period.

The use of Genetically Modified (GM) products, such as GM animals, developed using the rDNA method are found to be indispensable to accelerate medical research. Furthermore, more than 3000 scientific studies have been carried out to assess GM product safety in context to its impact on human health and the environment.

In addition, there is a rising need to improve the recombinant proteins’ production capacity by several folds, owing to an increase in demand for effective therapeutics for disease treatment. The aforementioned fact pronounces the technological advances in this sector thus driving growth.

As per Monsanto and other proponents of GM crops, genetic engineering is one of the fastest and widely adopted agricultural innovations over the past few years. This, in turn, is expected to bolster the adoption of rDNA technology for non-traditional applications.

Recombinant DNA Technology Market Report Highlights
  • Medical rDNA products dominated the share in 2023 in terms of revenue generation.
  • This can be attributed to the commercial success of insulin which has prompted firms for further development of recombinant drugs.
  • Owing to efficient transient and stable expression capabilities, mammalian expression system captured the largest share.
  • This share is also supported by the improvements in media for high yield using a mammalian expression system.
  • Health & disease accounted with the largest share in terms of revenue.
  • Gene therapy, antibodies production, drug metabolism investigation, recombinant therapeutic & vaccine development are recognized as major applications of this technology in human healthcare management.
  • Various end-use segments served by this recombinant DNA technology market encompass pharmaceutical & biotech entities, academic & research institutes, and other industrial entities.
  • End-use wise, pharmaceutical and biotechnology firms are estimated to be the largest segment owing to the presence of a substantial number of biopharma entities that have adopted rDNA products.
  • North America held the largest share owing to the presence of effective regulations pertaining to the approval of recombinant therapeutics as well as GM products.
  • Asia Pacific is expected to emerge as the fastest growing regional market.
  • Conducting clinical trials in Asian countries such as India is relatively less expensive compared to western countries. This has resulted in the migration of several global biopharmaceutical developers towards this region.
  • Biogen; Amgen Inc., Eli Lilly and Company, Monsanto Company, Novartis AG, and F. Hoffmann-La Roche Ltd are some of the major companies operating in this space.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

CHAPTER 3. RECREATIONAL OXYGEN EQUIPMENT MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
3.4. Recreational Oxygen Equipment Market Analysis Tools
  3.4.1. Porter’s Analysis
    3.4.1.1. Bargaining power of the suppliers
    3.4.1.2. Bargaining power of the buyers
    3.4.1.3. Threats of substitution
    3.4.1.4. Threats from new entrants
    3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
    3.4.2.1. Political landscape
    3.4.2.2. Economic and Social landscape
    3.4.2.3. Technological landscape
    3.4.2.4. Environmental landscape
    3.4.2.5. Legal landscape

CHAPTER 4. RECREATIONAL OXYGEN EQUIPMENT MARKET: PRODUCT ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Recreational Oxygen Equipment Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Oxygen Concentrators
  4.3.1. Oxygen Concentrators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Oxygen Bar Equipment
  4.4.1. Oxygen Bar Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Others
  4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. RECREATIONAL OXYGEN EQUIPMENT MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Recreational Oxygen Equipment Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Athletics
  5.3.1. Athletics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Medical
  5.4.1. Medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
  5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. RECREATIONAL OXYGEN EQUIPMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

6.1. Recreational Oxygen Equipment Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
  6.2.1. North America Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.2. U.S.
    6.2.2.1. U.S. Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.3. Canada
    6.2.3.1. Canada Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.2.4. Mexico
    6.2.4.1. Mexico Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
  6.3.1. Europe Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.2. UK
    6.3.2.1. UK Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.3. Germany
    6.3.3.1. Germany Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.4. France
    6.3.4.1. France Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.5. Italy
    6.3.5.1. Italy Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.6. Spain
    6.3.6.1. Spain Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.7. Russia
    6.3.7.1. Russia Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
  6.4.1. Asia Pacific Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.2. China
    6.4.2.1. China Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.3. India
    6.4.3.1. India Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.4. Japan
    6.4.4.1. Japan Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.5. Australia
    6.4.5.1. Australia Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.6. South Korea
    6.4.6.1. South Korea Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.7. Singapore
    6.4.7.1. Singapore Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
  6.5.1. Latin America Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.2. Brazil
    6.5.2.1. Brazil Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.3. Argentina
    6.5.3.1. Argentina Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
  6.6.1. Middle East and Africa Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.2. South Africa
    6.6.2.1. South Africa Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.3. Saudi Arabia
    6.6.3.1. Saudi Arabia Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.4. UAE
    6.6.4.1. UAE Recreational Oxygen Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
  7.4.1. Oxygen Plus. Inc.
    7.4.1.1. Participant’s Overview
    7.4.1.2. Financial Performance
    7.4.1.3. Product Benchmarking
    7.4.1.4. Recent Developments/ Strategic Initiatives
  7.4.2. Koninklijke Philips N.V.
    7.4.2.1. Participant’s Overview
    7.4.2.2. Financial Performance
    7.4.2.3. Product Benchmarking
    7.4.2.4. Recent Developments/ Strategic Initiatives
  7.4.3. Boost Oxygen, LLC.
    7.4.3.1. Participant’s Overview
    7.4.3.2. Financial Performance
    7.4.3.3. Product Benchmarking
    7.4.3.4. Recent Developments/ Strategic Initiatives
  7.4.4. CAIRE Inc.
    7.4.4.1. Participant’s Overview
    7.4.4.2. Financial Performance
    7.4.4.3. Product Benchmarking
    7.4.4.4. Recent Developments/ Strategic Initiatives
  7.4.5. Chart Industries
    7.4.5.1. Participant’s Overview
    7.4.5.2. Financial Performance
    7.4.5.3. Product Benchmarking
    7.4.5.4. Recent Developments/ Strategic Initiatives
  7.4.6. Invacare Corporation
    7.4.6.1. Participant’s Overview
    7.4.6.2. Financial Performance
    7.4.6.3. Product Benchmarking
    7.4.6.4. Recent Developments/ Strategic Initiatives
  7.4.7. Korrida
    7.4.7.1. Participant’s Overview
    7.4.7.2. Financial Performance
    7.4.7.3. Product Benchmarking
    7.4.7.4. Recent Developments/ Strategic Initiatives
  7.4.8. Inogen, Inc.
    7.4.8.1. Participant’s Overview
    7.4.8.2. Financial Performance
    7.4.8.3. Product Benchmarking
    7.4.8.4. Recent Developments/ Strategic Initiatives
  7.4.9. Zadro Inc.
    7.4.9.1. Participant’s Overview
    7.4.9.2. Financial Performance
    7.4.9.3. Product Benchmarking
    7.4.9.4. Recent Developments/ Strategic Initiatives
  7.4.10. 2ND WIND OXYGEN BARS
    7.4.10.1. Participant’s Overview
    7.4.10.2. Financial Performance
    7.4.10.3. Product Benchmarking
    7.4.10.4. Recent Developments/ Strategic Initiatives
  7.4.11. VitalAire
    7.4.11.1. Participant’s Overview
    7.4.11.2. Financial Performance
    7.4.11.3. Product Benchmarking
    7.4.11.4. Recent Developments/ Strategic Initiatives
  7.4.12. VitalityNow
    7.4.12.1. Participant’s Overview
    7.4.12.2. Financial Performance
    7.4.12.3. Product Benchmarking
    7.4.12.4. Recent Developments/ Strategic Initiatives


More Publications